Sponsor
Huashan Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Huashan Hospital appears in 63 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownIdentification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental IllnessNCT07571226 · lead sponsor · 2026-04-10
RECRUITINGSGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose MetabolismNCT07482020 · lead sponsor · 2025-03-01
RECRUITINGEstablishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple NeuroimagingNCT06827678 · lead sponsor · 2022-08-01
RECRUITINGA Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyNCT07341828 · lead sponsor · 2026-02-01
NOT_YET_RECRUITINGThis is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple SclerosisNCT07364487 · lead sponsor · 2026-01-26
WITHDRAWNDetection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA)NCT04536857 · lead sponsor · 2024-10-01
WITHDRAWNaSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled TrialNCT06288659 · lead sponsor · 2024-07-19
ACTIVE_NOT_RECRUITINGA Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate CancerNCT06201741 · lead sponsor · 2023-12-27
UNKNOWNCSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain ImagingNCT06148233 · lead sponsor · 2023-09-15
UNKNOWNAmphotericin B for Non-HIV Cryptococcal Meningitis PatientsNCT06178627 · lead sponsor · 2023-08-13
UNKNOWNThe Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19NCT05855395 · lead sponsor · 2023-05-26
UNKNOWNStudy of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast CancerNCT05982626 · lead sponsor · 2023-05-15
UNKNOWN[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung CancerNCT06165874 · lead sponsor · 2023-03-12
UNKNOWNComparison of Body Weight Change Through Different Smeglutide Administration MethodsNCT05616052 · lead sponsor · 2022-12-01
UNKNOWNResearch on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With DiabetesNCT05641337 · lead sponsor · 2022-10-01
UNKNOWNInterleaving Stimulation Improves Dyskinesia in Parkinson's DiseaseNCT06239454 · lead sponsor · 2022-03-01
UNKNOWNA Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health CenterNCT05081440 · lead sponsor · 2021-12-01
UNKNOWNThe Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's DiseaseNCT05372458 · lead sponsor · 2021-01-01
UNKNOWNCardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in HypertensivesNCT04531124 · lead sponsor · 2020-09-01
UNKNOWNStudy of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung CancerNCT04260295 · lead sponsor · 2019-11-01
UNKNOWNProspective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPDNCT04259736 · lead sponsor · 2019-01-01
UNKNOWNA Pilot Study to Evaluate the Severity of Motor Dysfunction in Parkinson's Disease Based on AI Video AnalysisNCT03655171 · lead sponsor · 2018-08-20
COMPLETEDEfficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACONCT03504527 · lead sponsor · 2018-05-01
UNKNOWNEfficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPDNCT03258749 · lead sponsor · 2017-11-01
UNKNOWNStudy of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPDNCT03277001 · lead sponsor · 2017-10-01
UNKNOWNEealy Improvement Predicts Antidepressants Response in Adults With Major Depression DisorderNCT03230682 · lead sponsor · 2017-07-25
UNKNOWNHospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional StudyNCT03862183 · lead sponsor · 2017-07-01
UNKNOWNProspective Clinical Study of PCV and PCV-VG in Patients Undergoing Bariatric SurgeryNCT03150264 · lead sponsor · 2017-01-16
UNKNOWNThe Impact of Resistance Training on Type 2 Diabetes Patients.NCT02413060 · lead sponsor · 2015-03-01
UNKNOWNPharmacokinetics Study of Gamma-aminobutyric AcidNCT01917760 · lead sponsor · 2013-07-01
COMPLETEDEffects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 DiabetesNCT01781884 · lead sponsor · 2013-01-01
UNKNOWNEffects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic DamageNCT01783717 · lead sponsor · 2012-12-01
UNKNOWNThe Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's DiseaseNCT01470859 · lead sponsor · 2011-12-01
COMPLETEDThe Detection and Factors of Brown Adipose Tissue in Different Locations of AdultsNCT01387451 · lead sponsor · 2010-10-01
UNKNOWNThe Incidence and Factors of Brown Adipose Tissue in ChineseNCT01381042 · lead sponsor · 2010-02-01
UNKNOWNThe Incidence,Factors,and Importance of Brown Adipose Tissue in Chinese AdultsNCT01387438 · lead sponsor · 2009-12-01
UNKNOWNA Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLCNCT07434518 · collaborator · 2026-01-27
RECRUITINGShanghai Clinical Cohort - Parkinson's Disease (Reserve)NCT07353463 · collaborator · 2025-04-01
RECRUITINGEfficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental DisordersNCT06112067 · collaborator · 2023-10-16
RECRUITINGPatient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap ReconstructionNCT05512286 · collaborator · 2022-08-25
RECRUITINGDetection of Alzheimer's Disease (AD)-Related Seeds for AD DiagnosisNCT04850053 · collaborator · 2020-08-26
RECRUITINGClinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's DiseaseNCT03810794 · collaborator · 2019-03-01
RECRUITINGThe Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's DiseaseNCT05020106 · collaborator · 2018-09-01
RECRUITINGChina Health Big DataNCT03699228 · collaborator · 2017-12-01
RECRUITINGDapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate CancerNCT07310433 · collaborator · 2026-06-01
NOT_YET_RECRUITINGPosterior Extra-fascial RARP in Intermediate or High Risk Prostate CancerNCT06434649 · collaborator · 2025-11-01
ACTIVE_NOT_RECRUITINGA Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With InfectionNCT06280001 · collaborator · 2024-03-01
NOT_YET_RECRUITINGEfficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseNCT05611372 · collaborator · 2023-01-01
WITHDRAWNHippocampus DBS in Treatment-resistant SchizophreniaNCT05694000 · collaborator · 2022-11-01
UNKNOWNPrevention of PONV With Traditional Chinese MedicineNCT05375721 · collaborator · 2022-09-23
UNKNOWNPost-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral NeuropathyNCT04711980 · collaborator · 2021-06-01
UNKNOWNLiraglutide Plus Megestrol Acetate in Endometrial Atypical HyperplasiaNCT04683237 · collaborator · 2021-03-20
WITHDRAWNAsymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label StudyNCT04616521 · collaborator · 2021-01-01
NOT_YET_RECRUITINGOptimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment ClassificationNCT04528628 · collaborator · 2020-10-01
UNKNOWNA Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson DiseaseNCT04152655 · collaborator · 2020-01-01
WITHDRAWNDiagnostic, Risk Stratification and Prognostic Value of Novel Biomarkers in Patients With Heart FailureNCT03727828 · collaborator · 2018-11-15
UNKNOWNQuality Control and Evaluation in Standard COPD ManagementNCT03314077 · collaborator · 2017-11-01
COMPLETEDStereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLCNCT04912128 · collaborator · 2017-01-15
COMPLETEDMulti-center Imaging Genetics Studies in ChinaNCT02681822 · collaborator · 2015-11-01
UNKNOWNThe Efficacy And Cognitive Impairment Of Modified Electroconvulsive TherapyNCT02066077 · collaborator · 2013-01-01
COMPLETEDDrugs studied in this sponsor's trials
15 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Huashan Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo3
donepezil1
enoxaparin1
etomidate1
exenatide1
formoterol1
idebenone1
megestrol acetate 160 MG1
placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting
3 trials
donepezil RxCUI 135447 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
enoxaparin RxCUI 67108 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
etomidate RxCUI 4177 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
exenatide RxCUI 60548 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
formoterol RxCUI 25255 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
idebenone RxCUI 51296 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
megestrol acetate 160 MG RxCUI 860230 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
placebo Oral Tablet RxCUI 375221 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
pramipexole RxCUI 746741 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
propofol RxCUI 8782 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
rasagiline RxCUI 134748 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
rivaroxaban RxCUI 1114195 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
semaglutide RxCUI 1991302 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
tiotropium RxCUI 69120 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor36
collaborator27
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.